Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
combination therapy
Biotech
Amgen and Ideaya ax cancer combination trial
Amgen and Ideaya mutually agreed to wind the current study down and drop plans to start dose expansion.
Nick Paul Taylor
Feb 13, 2025 7:34am
Lilly's oral SERD Ember counts on Verzenio to broaden its glow
Dec 11, 2024 8:15am
Vir keeps pressure on Gilead with midphase hepatitis D data
Jun 5, 2024 8:52am
ASCO: Regeneron misses mark with one CR in solid tumor trial
May 23, 2024 5:00pm
Calliditas' cancer trial misses primary goal, hits on survival
May 7, 2024 6:39am
New immunotherapy drug design ups survival in mice with cancer
Apr 23, 2024 3:40am